Response to nab-paclitaxel plus gemcitabine in a patient with primary resistance to FOLFIRINOX.

J Gastrointest Cancer

Department of Internal Medicine (Division of Oncology) and Center for Investigational Therapeutics, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Suite 2100, Salt Lake City, UT, 84112, USA.

Published: December 2014

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12029-014-9662-3DOI Listing

Publication Analysis

Top Keywords

response nab-paclitaxel
4
nab-paclitaxel gemcitabine
4
gemcitabine patient
4
patient primary
4
primary resistance
4
resistance folfirinox
4
response
1
gemcitabine
1
patient
1
primary
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!